Search Results
Scientific Insights Into LDL-C, PCSK9, and CV RISKS
The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)
Are PCSK9 Inhibitors for LDL Cholesterol Safe and Effective?
ApoB Levels and Heart Disease: What You Need to Know | Daniel Soffer | The Proof Podcast EP #339
Blood Lipids and Cardiovascular Risk: Everything You Need to Know
Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?
Dr Aruna Pradhan - Have we reached the limits of lipid lowering? What next? - Full version
Cholesterol & Heart Health: Insights from LDL Research on Keto with Dave Feldman & Nick Norwitz, PhD
The Cholesterol Wars: The Critical Importance of Lowering LDL-C in High-Risk Patients
Beyond LDL-C: Atherogenic Lipoproteins and CVD Risk
PCSK9 antagonists: A real breakthrough for management of familial hypercholesterolaemia? ESC2016
Inclisiran: How it revolutionizes cholesterol management!
